1. Home
  2. ALMS vs EFR Comparison

ALMS vs EFR Comparison

Compare ALMS & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • EFR
  • Stock Information
  • Founded
  • ALMS 2021
  • EFR 2003
  • Country
  • ALMS United States
  • EFR United States
  • Employees
  • ALMS N/A
  • EFR N/A
  • Industry
  • ALMS
  • EFR Trusts Except Educational Religious and Charitable
  • Sector
  • ALMS
  • EFR Finance
  • Exchange
  • ALMS NYSE
  • EFR Nasdaq
  • Market Cap
  • ALMS 469.0M
  • EFR 382.5M
  • IPO Year
  • ALMS 2024
  • EFR N/A
  • Fundamental
  • Price
  • ALMS $8.82
  • EFR $12.95
  • Analyst Decision
  • ALMS Strong Buy
  • EFR
  • Analyst Count
  • ALMS 6
  • EFR 0
  • Target Price
  • ALMS $29.60
  • EFR N/A
  • AVG Volume (30 Days)
  • ALMS 148.8K
  • EFR 88.6K
  • Earning Date
  • ALMS 02-15-2025
  • EFR 01-01-0001
  • Dividend Yield
  • ALMS N/A
  • EFR 9.43%
  • EPS Growth
  • ALMS N/A
  • EFR N/A
  • EPS
  • ALMS N/A
  • EFR 1.69
  • Revenue
  • ALMS N/A
  • EFR N/A
  • Revenue This Year
  • ALMS N/A
  • EFR N/A
  • Revenue Next Year
  • ALMS N/A
  • EFR N/A
  • P/E Ratio
  • ALMS N/A
  • EFR $7.74
  • Revenue Growth
  • ALMS N/A
  • EFR N/A
  • 52 Week Low
  • ALMS $7.66
  • EFR $10.95
  • 52 Week High
  • ALMS $13.53
  • EFR $13.29
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • EFR 49.69
  • Support Level
  • ALMS N/A
  • EFR $12.76
  • Resistance Level
  • ALMS N/A
  • EFR $13.12
  • Average True Range (ATR)
  • ALMS 0.00
  • EFR 0.11
  • MACD
  • ALMS 0.00
  • EFR -0.03
  • Stochastic Oscillator
  • ALMS 0.00
  • EFR 50.08

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of health care, industrial equipment, lodging and casinos, oil and gas, publishing, radio and television, telecommunications, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

Share on Social Networks: